These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4348741)

  • 21. Production, isolation, and partial characterization of three foot-and-mouth disease virus temperature-sensitive mutants.
    Richmond JY
    Infect Immun; 1975 Jun; 11(6):1291-5. PubMed ID: 166915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of mutants of foot-and-mouth disease virus obtained by cultivation at low temperature. Selection of strains non-pathogenic in swine].
    Asso J; Aynaud JM; Plart MF
    Ann Inst Pasteur (Paris); 1966 Feb; 110(2):233-43. PubMed ID: 4285751
    [No Abstract]   [Full Text] [Related]  

  • 23. Improved technique for the isolation of temperature-sensitive mutants of foot-and-mouth disease virus.
    Lake J; Mackenzie JS
    J Virol; 1973 Sep; 12(3):665-8. PubMed ID: 4355865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the population composition of foot-and-mouth disease virus during the course of a modification in the central nervous system of mice].
    Wagner S
    Arch Exp Veterinarmed; 1966 Sep; 20(4):825-38. PubMed ID: 4298118
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenotypic and functional characterization of mouse attenuated and virulent variants of foot-and-mouth disease virus type O1 Campos.
    Jensen MJ; Moore DM
    Virology; 1993 Apr; 193(2):604-13. PubMed ID: 8384748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 27. Further isolation and characterization of temperature-sensitive mutants of influenza virus.
    Sugiura A; Ueda M; Tobita K; Enomoto C
    Virology; 1975 Jun; 65(2):363-73. PubMed ID: 1168970
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of frog virus 3 on the biological activity of various RNA viruses.
    Barzilai R; Lachmi BE
    J Gen Virol; 1973 Oct; 21():201-4. PubMed ID: 4357374
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemical and physical properties of foot-and-mouth disease virus: a comparison with Maus Elberfeld virus.
    Vande Woude GF; Swaney JB; Bachrach HL
    Biochem Biophys Res Commun; 1972 Sep; 48(5):1222-9. PubMed ID: 4341052
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of interferon and guanidine on the inactivation of RNA of foot-and-mouth disease virus infected cells].
    Ahl R
    Hoppe Seylers Z Physiol Chem; 1973; 354(10-11):1164-5. PubMed ID: 4373360
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of foot and mouth disease virus and procapsid synthesis by zinc ions. Brief report.
    Firpo EJ; Palma EL
    Arch Virol; 1979; 61(1-2):175-81. PubMed ID: 229792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Deviations of a 1st order reaction in the inactivation of foot-and-mouth disease (FMS) virus with hydroxylamine].
    Wittmann G; Bauer K
    Zentralbl Bakteriol Orig; 1968; 207(2):259-61. PubMed ID: 4314371
    [No Abstract]   [Full Text] [Related]  

  • 33. Inactivation of foot-and-mouth disease virus with ethylenimine.
    Cunliffe HR
    Appl Microbiol; 1973 Nov; 26(5):747-50. PubMed ID: 4357652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the kinetics of protein and RNA synthesis induced by foot-and-mouth disease virus.
    Brown F; Martin SJ; Underwood B
    Biochim Biophys Acta; 1966 Oct; 129(1):166-77. PubMed ID: 4291133
    [No Abstract]   [Full Text] [Related]  

  • 35. Further studies of the physical and metabolic properties of foot-and-mouth disease virus temperature-sensitive mutants.
    Richmond JY; Polatnick J
    Infect Immun; 1976 May; 13(5):1392-6. PubMed ID: 5377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of temperature-sensitive Akabane virus mutants and their roles in attenuation.
    Ogawa Y; Kato K; Tohya Y; Akashi H
    Arch Virol; 2007; 152(9):1679-86. PubMed ID: 17533552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribosomal factors effecting the stimulation of cell-free protein synthesis in the prescence of foot-and-mouth disease virus ribonucleic acid.
    Ascione R; Vande Woude GF
    Biochem Biophys Res Commun; 1971 Oct; 45(1):14-21. PubMed ID: 4334521
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic characteristics of clones from individual cells multiply-infected with different strains of foot-and-mouth disease virus.
    Slade WR; Pringle CR
    J Gen Virol; 1971 Sep; 12(3):335-9. PubMed ID: 4330350
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydroxylamine as an inactivating agent for foot-and-mouth disease virus.
    Fellowes ON
    J Immunol; 1966 May; 96(5):772-6. PubMed ID: 4288021
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation and basic properties of temperature--sensitive mutants of Venezuelan equine encephalomyelitis virus.
    Vladyko GV; Tsilinsky YY
    Acta Virol; 1980 Jan; 24(1):29-36. PubMed ID: 6104432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.